Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
Coronavirus disease 2019 (COVID-19) caused a progress in research to find a solution to this pandemic. Also, various advances in pharmacotherapy against COVID-19 have emerged. Regarding antiviral therapy, casirivimab and imdevimab are antibodies combination against COVID-19. Standard antiviral thera...
Asıl Yazarlar: | Hegazy Sahar K., Tharwat Samar, Hassan Ahmed H. |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
De Gruyter
2023-08-01
|
Seri Bilgileri: | Open Medicine |
Konular: | |
Online Erişim: | https://doi.org/10.1515/med-2023-0768 |
Benzer Materyaller
-
Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients
Yazar:: Sahar K. Hegazy, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01) -
The effect of casirivimab with imdevimab on disease progression in nonsevere COVID‐19 patients in a single hospital in Japan
Yazar:: Junpei Komagamine, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01) -
An initial experience with antibody cocktail CASIRIVIMAB and IMDEVIMAB in a center of excellence: A retrospective case series of 3 patients and literature review
Yazar:: P Amal Johnson, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01) -
Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19
Yazar:: Netana H. Markovitz, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01) -
Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: A systematic review and meta-analysis randomized controlled trial
Yazar:: Imam Adi Wicaksono, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)